Related Experiment Videos
Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide
B Ganley1, G Chowdhury, J Bhansali
1Department of Chemistry, University of Missouri-Columbia, Columbia, MO 65211, USA.
Bioorganic & Medicinal Chemistry
|September 13, 2001
Summary
Quinoxaline 1,4-dioxide demonstrates hypoxia-selective DNA cleavage in vitro. This finding provides a chemical basis for understanding the cytotoxic effects of these N-oxide compounds in low-oxygen environments.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Cancer Research
Background:
- Quinoxaline 1,4-dioxide (4) is a foundational compound for heterocyclic N-oxide antitumor agents.
- Previous studies suggested that hypoxic reduction of quinoxaline 1,4-dioxides causes DNA damage in bacterial cells.
Purpose of the Study:
- To explicitly characterize the DNA-cleaving ability of quinoxaline 1,4-dioxide (4) using in vitro assays.
- To investigate the hypoxia-selective DNA-cleaving properties of quinoxaline 1,4-dioxide (4).
Main Methods:
- In vitro DNA cleavage assays were employed to assess the activity of quinoxaline 1,4-dioxide (4).
- Experiments focused on characterizing the compound's behavior under low-oxygen (hypoxic) conditions.
Main Results:
- Quinoxaline 1,4-dioxide (4) was explicitly shown to cleave DNA in vitro.
- The compound exhibited hypoxia-selective DNA-cleaving properties.
Conclusions:
- The hypoxia-selective DNA-cleaving activity of quinoxaline 1,4-dioxide (4) provides a chemical basis for its biological effects.
- This mechanism may explain the cytotoxic and mutagenic activities observed for quinoxaline 1,4-dioxide antibiotics.